Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 13Genitourinary 8Gastrointestinal 8Head & Neck 7Other 5Lymphoid 4Thoracic 3Other hematologic neoplasm 3Gynecologic 3Sarcoma 2Plasma cell 2Endocrine 2CNS 2Tumor-Agnostic 1Other solid neoplasm 1

Conditions

Pituitary Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Motor Activity 1Limb-girdle muscular dystrophy, type 2C 1Diabetes Mellitus, Type 2 1Diabetes Mellitus 1

Interventions

Everolimus 32Octreotide 15Cisplatin 14pasireotide 13Sunitinib 13Temozolomide 11pembrolizumab 10Etoposide 10Doxorubicin 10lanreotide 9Magnetic Resonance Spectroscopy 9Bevacizumab 9lutetium Lu 177 dotatate 8gallium Ga 68 dotatate 8Sorafenib 8Paclitaxel 83-Iodobenzylguanidine 8lenvatinib 7pazopanib 6Radiotherapy 6Positron Emission Tomography Computed Tomography 6Nivolumab 6surufatinib 5cabozantinib 5avelumab 5Thyrotropin Alfa 5Surgical Procedures, Operative 5Radiosurgery 5Mitotane 5Irinotecan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Resistance Training × Endocrine × Clear all
NCT00786019 2023-07-12

InsITE

University of Colorado, Denver

Phase NA Completed
47 enrolled 22 charts
Endocrine

Limb-girdle muscular dystrophy, type 2C, Diabetes Mellitus, Diabetes Mellitus, Type 2, Motor Activity, Multiple Endocrine Neoplasia Type 1

NCT04284605 2021-10-27

Effects Exercise Training in Patients With Pituitary Adenoma

Hacettepe University

Phase NA Completed
10 enrolled
Endocrine

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡